Hemodialysis
Conditions
Interventions
Change from using conventional polysulfone dialyzer to using good biocompatibility dialyzer(NV) (for 6 months).
Change from using good biocompatibility dialyzer(NV) to using conventional polysulfone d
Sponsors
Oita university hospital Blood Purification Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patients whose age is between 20 and 80 years at the time of enrollment in this study. 2) The patients who are using polysulfone dialyzers (NV or except NV).
Exclusion criteria
Exclusion criteria: 1) A patient who is treated with other renal insufficiency therapies, continuous ambulatory peritoneal dialysis and hemodiafiltration, excluding hemodialysis. 2) A patient who is enrolled to other clinical study. 3) Cancer bearing patients. 4) A patient who has anamnestic cardiovascular diseases (heart attack, stroke) in less than 3 months. 5) A patient who is consider as onset of acute inflammation. 6) A patient who is a pregnant or intends to become a pregnant within one year. 8) A patient who is judged as the inadequate subject of this study by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Use NV dialyzer and conventional polysulfone dialyzer and compare the blood marker levels. Measurement marker Plasma free radical IL-6 Pentraxin 3 Fetuin A High sensitive CRP Homocysteine Pentosidine | — |
Countries
Japan
Contacts
Public ContactKaede Ishida
Oita university hospital Blood Purification Center
Outcome results
None listed